We use cookies to give you the best possible experience on our website.



CIMIT CRAASH Graduates Move on to Win $225K in Funding to Advance Novel Measurement Technology

Cerillo, a technology company focused on changing the way researchers measure anaerobic bacterial growth, has won a $225K Small Business Innovation Research (SBIR) Phase I award to advance their novel bacterial measurement technology.
Read MoreAboutCIMIT CRAASH Graduates Move on to Win $225K in Funding to Advance Novel Measurement Technology »

Mini Plate Reader Wins 5K for Excellence in Innovation from CIMIT’s CRAASH Course

On July 14, 2016, CIMIT completed the third session of the CRAASH program, a course focusing on innovation in the healthtech space. Six teams presented final pitches at the end of the intensive 10-week program. Team “Mini Plate Reader” was a highlight among the six projects this semester.
Read MoreAboutMini Plate Reader Wins 5K for Excellence in Innovation from CIMIT’s CRAASH Course »

Learning to Commercialize Healthcare Innovation

“4 out of 10 start ups fail because they’ve built something no one wants to buy,” says Mike Dempsey, CIMIT’s Entrepreneur in Residence and Accelerator Program Leader. “They haven’t taken the time to ask the tough questions to really understand their economic buyer.”
Read MoreAboutLearning to Commercialize Healthcare Innovation »

BOLD Diagnostics, LLC Places Fourth Place In 2016 Rice Business Plan Competition

Bold Diagnostics, LLC from Northwestern University emerged as the fourth place startup company in the Rice Business Plan Competition (RBPC) hosted by the Rice Alliance for Technology and Entrepreneurship. The annual event is the world’s richest and largest student startup competition.
Read MoreAboutBOLD Diagnostics, LLC Places Fourth Place In 2016 Rice Business Plan Competition »

PhotoniCare Wins CRAASH Prize For Excellence In Innovation

On April 8, 2016, CIMIT hosted 9 project teams during the closeout session for the winter session of its CRAASH course. Teams took to the podium to present final pitches; the culmination of 10 weeks of intensive work to accelerate their healthtech innovations out of the lab toward commercialization and clinical practice, with PhotoniCare standing out as a leader among the strong teams who participated.
Read MoreAboutPhotoniCare Wins CRAASH Prize For Excellence In Innovation »


Avoiding Deal Killers

In today’s environment, even promising healthech innovations fail to get investments from financially motivated investors. As a result, solutions do not survive the so-called Valley of Death. There are numerous good reasons why investors choose not to invest. In many cases, it is because the innovator did not anticipate and prepare a response to a question about a particular risk. This can be traced back to the fact that innovators often fail to put themselves in an investor’s shoes. Doing so is critical to understanding why they may not invest in their solution—the “deal killers”.

Read More »

National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network

This paper describes the POCTRN and the three currently funded Centers as examples of academic-based organizations that support  collaborations across disciplines, institutions, and geographic regions to successfully drive innovative solutions from concept to patient care.

Read More »

Healthcare Commercialization Programs

Healthcare commercialization programs (HCPs) are described and proposed as an option that institutions can add to their portfolio to improve translational research. In helping teams translate specifc healthcare innovations into practice, HCPs expand the skillset of investigators and enhance an institution's innovation capacity. Lessons learned are shared from configuring and delivering HCPs, which build on the fundamentals of the National Science Foundation's Innovation Corps program, to address the unique challenges in supporting healthcare innovations and innovators.

Read More »

2014 CIMIT Clinical Impact Study Update

This is an ongoing, work-in-process update of CIMIT’s Clinical Impact Study (CIS). First conducted in 2009, the CIS is a self-assessment by CIMIT faculty and investigators of its project portfolio and Accelerator Program and now includes projects initiated between 1998 and 2012. The innovation portfolio, an important subset of the ways in which CIMIT helps speed innovations into patient care, represents an investment of almost $70M over 14 years. It also represents a rather unique longitudinal set of experiences from which to learn.

Read More »

IEEE Pulse Featuring CIMIT

If ever an industry was in need of both incremental and disruptive innovation it is today's health care industry. Realizing the full potential of innovation across the spectrum of health care environments is critical to address the well-documented, emerging global crisis generated by the aging of the population, the obligation to increase access for all to the best standard of care, and the societal imperative to contain costs.

Read More »

Facilitating Translational Research

Would a carpenter be asked to manage building a new housing development? Probably not. More likely a real estate developer with the skills, experience and knowledge of the local market and trades, including carpentry, would manage such an undertaking. Good developers anticipate and address the challenges of building and selling homes. Delivering attractive appropriately priced homes on time and on budget requires that developers use their knowledge, experience, and judgment to make numerous decisions that engage the right talent at the right time to balance development risks and costs.

Read More »

Venture Findings Featuring the CIMIT Model

The Consortia for Improving Medicine with Innovation & Technology (CIMIT) was established in 1998 by four leading academic medical centers and universities in the greater Boston area to leverage the value of a consortium to improve patient care through Deep Innovation using medical technology to solve pressing unmet medical needs.

Read More »